摘要
目的:构建携带抑癌基因Fhit的重组腺病毒并通过其研究Fhit蛋白对结直肠癌细胞增殖能力的影响。方法:利用PCR方法从人胎肝文库中克隆Fhit基因片段,Fhit基因PCR产物连入T载体构建重组质粒pMD18T-Fhit。测序正确后,将基因片段导入ptrack-CMV穿梭质粒中,构建重组穿梭载体ptrack-CMV-Fhit。将经PmeⅠ单酶切线性化的ptrack-CMV-Fhit和骨架腺病毒质粒pAdEasy-1共转BJ5183大肠杆菌,使ptrack-CMV-Fhit和pAdEasy-1发生同源重组。经PacI酶切鉴定正确后,将重组腺病毒质粒转染293A细胞获得表达Fhit蛋白的重组腺病毒rAd-Fhit,将获得的重组腺病毒感染结肠癌细胞,采用蛋白印迹法检测外源Fhit蛋白的表达,并进一步观察其对细胞增殖能力的影响。结果:成功构建了携带有Fhit基因的重组腺病毒,且能够在结肠癌细胞中成功表达Fhit蛋白。在结肠癌细胞中,Fhit蛋白明显减弱了结肠癌细胞的增殖能力。结论:在结肠癌细胞中,Fhit基因可能扮演抑癌基因的角色,而表达Fhit的重组腺病毒很可能成为一种结肠癌生物治疗的新策略。
AIM:To construct a recombinant adenovirus carrying Fhit gene,a tumor suppressor in many types of cancer,and to observe its biological function on the proliferation of colon cancer cells.METHODS:Fhit gene was cloned from the fetal liver cDNA library using the PCR method.The PCR product was inserted into the T vector to construct the plasmid pMD18T-Fhit.The Fhit fragment from the pMD18T-Fhit was inserted into the vector ptrack-CMV to construct a shuttle plasmid ptrack-CMV-Fhit.After PmeI digested and linearized process,ptrack-CMV-Fhit was co-transformed into Escherichia coli strain BJ5183 together with the adenovirus backbone vector pAdEasy-1 to generate a recombinant adenovirus plasmid by homologous recombination.The adenovirus plasmid was identified by PacI digestion and transfected into 293A cells to package a recombinant adenovirus which expressed the Fhit protein.Furthermore,the adenovirus rAd-Fhit was infected into colon cancer cells,and the expression of the ectogenic protein was detected by Western blotting.Finally,the proliferation of colon cancer cells was observed in adenovirus-infected cells by the MTT assay.RESULTS:Constructed the recombinant adenovirus encoding Fhit gene and expressed it in colon cancer cells successfully.Detected that the proliferation of colon cancer cells was inhibited obviously in rAd-Fhit-infected cells with comparison to the control groups.CONCLUSION:Fhit may function as a tumor suppressor in colon cancer cells,and the adenovirus-mediated Fhit can be a novel strategy for the colon cancer therapeutics.
出处
《中国生物工程杂志》
CAS
CSCD
北大核心
2010年第1期7-11,共5页
China Biotechnology
基金
国家自然科学基金(30873006
30901771)
第四军医大学"青年英才支持计划"(2009)
第四军医大学学员课外科研课题(2008)资助项目